Sun Pharma Approves INR 10,000 Cr NCD Issuance

Sun Pharmaceutical Industries Limited's Board of Directors met on October 12, 2026, and approved the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs) on a private placement basis. The aggregate amount for these NCDs will not exceed INR 10,000 Crore. The Board also approved the related issuance framework and authorized the Finance Committee to finalize tranche-specific terms. Additionally, the Board accepted the resignation of Mr. Gautam Doshi as a Non-Executive, Independent Director due to personal reasons, effective October 12, 2026. The Board expressed appreciation for his contributions.